UiPath Expands Healthcare Automation with New Global Professional Services Capabilities for Electronic Medical Records Platform
UiPath (NYSE: PATH) has secured a new global consulting agreement with a major Electronic Medical Records (EMR) platform, expanding its professional services to 16 new countries including Australia, France, Germany, Italy, Singapore, and Sweden. The agreement accelerates customer and partner access to EMR platform services from weeks to days.
This expansion aims to address healthcare efficiency challenges, as the EMR market for hospital systems is projected to exceed $20 billion in 2025. UiPath's automation and AI solutions focus on reducing administrative burden, improving revenue integrity, and optimizing interoperability in healthcare operations.
The company is also advancing its agentic automation capabilities, which combine large language models (LLMs), generative AI, and large action models (LAMs) to enable autonomous software agents that can perceive, reason, and execute tasks without constant human direction.
UiPath (NYSE: PATH) ha ottenuto un nuovo accordo di consulenza globale con una importante piattaforma di Cartelle Cliniche Elettroniche (EMR), espandendo i suoi servizi professionali in 16 nuovi paesi tra cui Australia, Francia, Germania, Italia, Singapore e Svezia. L'accordo accelera l'accesso dei clienti e dei partner ai servizi della piattaforma EMR da settimane a giorni.
Questa espansione mira a affrontare le sfide di efficienza nel settore sanitario, poiché si prevede che il mercato EMR per i sistemi ospedalieri supererà i 20 miliardi di dollari nel 2025. Le soluzioni di automazione e intelligenza artificiale di UiPath si concentrano sulla riduzione del carico amministrativo, sul miglioramento dell'integrità dei ricavi e sull'ottimizzazione dell'interoperabilità nelle operazioni sanitarie.
L'azienda sta anche avanzando nelle sue capacità di automazione agentica, che combinano modelli linguistici di grandi dimensioni (LLM), intelligenza artificiale generativa e modelli di azione di grandi dimensioni (LAM) per abilitare agenti software autonomi che possono percepire, ragionare ed eseguire compiti senza la continua direzione umana.
UiPath (NYSE: PATH) ha asegurado un nuevo acuerdo de consultoría global con una importante plataforma de Registros Médicos Electrónicos (EMR), ampliando sus servicios profesionales a 16 nuevos países, incluidos Australia, Francia, Alemania, Italia, Singapur y Suecia. El acuerdo acelera el acceso de clientes y socios a los servicios de la plataforma EMR de semanas a días.
Esta expansión tiene como objetivo abordar los desafíos de eficiencia en la atención médica, ya que se proyecta que el mercado de EMR para sistemas hospitalarios superará los 20 mil millones de dólares en 2025. Las soluciones de automatización e inteligencia artificial de UiPath se centran en reducir la carga administrativa, mejorar la integridad de los ingresos y optimizar la interoperabilidad en las operaciones de atención médica.
La empresa también está avanzando en sus capacidades de automatización agentiva, que combinan modelos de lenguaje de gran tamaño (LLM), IA generativa y modelos de acción de gran tamaño (LAM) para permitir agentes de software autónomos que pueden percibir, razonar y ejecutar tareas sin dirección humana constante.
UiPath (NYSE: PATH)는 주요 전자 의료 기록(EMR) 플랫폼과의 새로운 글로벌 컨설팅 계약을 체결하여 호주, 프랑스, 독일, 이탈리아, 싱가포르, 스웨덴을 포함한 16개 새로운 국가로 전문 서비스를 확장했습니다. 이 계약은 고객과 파트너가 EMR 플랫폼 서비스에 접근하는 시간을 몇 주에서 며칠로 단축합니다.
이번 확장은 의료 효율성 문제를 해결하기 위한 것으로, 2025년까지 병원 시스템의 EMR 시장이 200억 달러를 초과할 것으로 예상됩니다. UiPath의 자동화 및 AI 솔루션은 행정 부담을 줄이고, 수익 무결성을 개선하며, 의료 운영의 상호 운용성을 최적화하는 데 중점을 두고 있습니다.
회사는 또한 대규모 언어 모델(LLM), 생성 AI 및 대규모 행동 모델(LAM)을 결합하여 지속적인 인간 지시 없이 인식, 추론 및 작업을 실행할 수 있는 자율 소프트웨어 에이전트를 가능하게 하는 주체적 자동화 기능을 발전시키고 있습니다.
UiPath (NYSE: PATH) a conclu un nouvel accord de conseil mondial avec une importante plateforme de Dossiers Médicaux Électroniques (EMR), élargissant ses services professionnels à 16 nouveaux pays, y compris l'Australie, la France, l'Allemagne, l'Italie, Singapour et la Suède. Cet accord accélère l'accès des clients et des partenaires aux services de la plateforme EMR de plusieurs semaines à quelques jours.
Cette expansion vise à relever les défis d'efficacité dans le secteur de la santé, car le marché des EMR pour les systèmes hospitaliers devrait dépasser 20 milliards de dollars d'ici 2025. Les solutions d'automatisation et d'IA de UiPath se concentrent sur la réduction de la charge administrative, l'amélioration de l'intégrité des revenus et l'optimisation de l'interopérabilité dans les opérations de santé.
L'entreprise fait également progresser ses capacités d'automatisation agentique, qui combinent de grands modèles linguistiques (LLM), l'IA générative et de grands modèles d'action (LAM) pour permettre à des agents logiciels autonomes de percevoir, raisonner et exécuter des tâches sans direction humaine constante.
UiPath (NYSE: PATH) hat einen neuen globalen Beratungsvertrag mit einer bedeutenden Plattform für elektronische Patientenakten (EMR) abgeschlossen und seine professionellen Dienstleistungen auf 16 neue Länder ausgeweitet, darunter Australien, Frankreich, Deutschland, Italien, Singapur und Schweden. Der Vertrag beschleunigt den Zugang von Kunden und Partnern zu den EMR-Plattformdiensten von Wochen auf Tage.
Diese Expansion zielt darauf ab, die Herausforderungen der Effizienz im Gesundheitswesen anzugehen, da der EMR-Markt für Krankenhaus-Systeme bis 2025 voraussichtlich 20 Milliarden Dollar übersteigen wird. Die Automatisierungs- und KI-Lösungen von UiPath konzentrieren sich darauf, die administrative Belastung zu reduzieren, die Einnahmeintegrität zu verbessern und die Interoperabilität in den Gesundheitsoperationen zu optimieren.
Das Unternehmen entwickelt auch seine agentische Automatisierungsfähigkeiten weiter, die große Sprachmodelle (LLMs), generative KI und große Aktionsmodelle (LAMs) kombinieren, um autonome Software-Agenten zu ermöglichen, die Aufgaben ohne ständige menschliche Anleitung wahrnehmen, denken und ausführen können.
- Expansion to 16 new global markets beyond US and Canada
- Reduced EMR platform access time from weeks to days
- EMR market expected to grow beyond $20B by 2025
- Enhanced service delivery through strategic regional partnerships
- None.
Insights
UiPath's new global consulting agreement with a major EMR platform represents a significant strategic expansion in the healthcare automation sector. By extending professional services capabilities to 16 new countries including Australia, France, Germany, and Singapore, UiPath is positioning itself to capitalize on the
The value proposition is threefold: reducing the EMR access timeline from weeks to days, enabling closer collaboration with regional partners, and establishing a stronger global footprint in healthcare automation. This addresses a critical pain point in healthcare operations where providers often spend excessive time navigating EMR systems rather than focusing on patient care.
What makes this particularly noteworthy is the timing - as healthcare systems globally face mounting cost pressures and administrative burdens, UiPath's automation solutions offer concrete efficiency improvements without requiring complete system overhauls. The agreement also significantly expands UiPath's serviceable available market in healthcare, potentially accelerating adoption of their broader automation platform.
The emphasis on agentic automation capabilities positions UiPath at the intersection of healthcare administration and advanced AI - a strategic alignment with where enterprise technology is heading. This partnership model could serve as a template for UiPath to replicate across other industry-specific platforms, creating multiple vertical expansion paths beyond healthcare.
This EMR partnership represents a textbook land-and-expand strategy for UiPath in healthcare markets. By securing expedited access to a major EMR platform across 16 international markets, UiPath creates a critical entry point for its broader automation portfolio. The reduced access timeline (days versus weeks) removes a significant friction point that has historically slowed enterprise technology adoption in healthcare.
What's most compelling here is the potential compounding effect of UiPath's agentic automation approach. Traditional RPA has faced scaling challenges in complex environments like healthcare. By contrast, agentic automation with LLMs and LAMs can adapt to variations in EMR implementations across different healthcare systems and countries, potentially solving the customization bottleneck that plagues healthcare IT.
From a competitive perspective, this agreement creates important defensibility in the healthcare vertical. Competitors will now face higher barriers to entry in these markets without comparable EMR integration partnerships. UiPath has effectively positioned itself as an acceleration layer atop existing EMR investments rather than a replacement technology - a pragmatic approach given healthcare's aversion to ripping out core systems.
While financial terms remain undisclosed, the strategic value lies in diversifying UiPath's revenue opportunities beyond its North American base into growth markets. This geographic expansion also provides insulation against regional economic fluctuations while potentially improving overall customer retention through deeper healthcare system integration.
UiPath Platform™ enables faster access to a major EMR for customers and partners in 16 new global locations
EMRs are the backbone of modern healthcare, connecting patients, providers, and payers with vital information. While these platforms enhance the patient-provider experience, the overwhelming volume of work needed in the EMR means many healthcare providers spend more time with data than with patients, billing administrators are saddled with claims, and IT departments must orchestrate interoperability between services.
With the new agreement, customers and partners can now gain access in days rather than weeks, and UiPath can work more closely with strategic regional partners to provide customers with expanded options in talent and price point. New locations supported beyond the
Automation and AI can help providers by reducing administrative and clinical abrasion, increasing revenue integrity, and lowering costs through optimizing interoperability and application testing.
“The EMR market for hospital systems alone is expected to grow beyond
Critically, as agentic automation and agentic AI grow in adoption, UiPath can help customers and partners scale their support for agentic solutions. Agentic automation enables software agents, powered by large language models (LLMs), generative AI (GenAI), and large action models (LAMs), as well as other advanced AI, to take autonomous action. Agentic automation agents can perceive their environment, reason and ask questions about it, and formulate and execute a set of actions to achieve specific goals.
People do not need to structure and direct these agents’ work; rather, agents themselves can assess data, recognize patterns, formulate new questions, draw conclusions, structure processes to get the work done, and execute the work.
Click here to discover how UiPath can drive agentic automation and other automation transformation in healthcare.
About UiPath
UiPath (NYSE: PATH) develops AI technology that mirrors human intelligence with ever-increasing sophistication, transforming how businesses operate, innovate, and compete. The UiPath Platform™ accelerates the shift toward a new era of agentic automation—one where agents, robots, people, and models integrate seamlessly to enable autonomous processes and smarter decision making. With a focus on security, accuracy, and resiliency, UiPath is committed to shaping a world where AI enhances human potential and revolutionizes industries. For more information, visit www.uipath.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250303149241/en/
Media Contact
UiPath
pr@uipath.com
Investor Relations Contact
UiPath
investor.relations@uipath.com
Source: UiPath
FAQ
What is the geographical expansion scope of UiPath's new EMR consulting agreement?
How does the new PATH agreement improve EMR platform access time?
What is the projected market size for hospital EMR systems by 2025?
How does UiPath's agentic automation enhance healthcare operations?
What are the main benefits of UiPath's EMR automation for healthcare providers?
